col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

104 Results       Page 1

BMJ: Journal of Neurology Neurosurgery & Psychiatry
  original article Date Title Authors   All Authors
1 [GO] 2023―Oct―26 Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels Julie A Campbell, Ingrid van der Mei, Bruce V Taylor, Andrew J Palmer, Glen J Henson, Laura Louise Laslett, et al. (+2)
2 [GO] 2023―Oct―19 COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study Federico Montini, Agostino Nozzolillo, Nicolò Tedone, Damiano Mistri, Paola MV Rancoita, Chiara Zanetta, et al. (+6)
3 [GO] 2023―Jul―21 Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders? Lina Jeantin, Basma Abdi, Cathia Soulié, Delphine Sterlin, Elisabeth Maillart, Ysoline Beigneux, et al. (+5)
4 [GO] 2023―Apr―25 Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses Frederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, Anna Christine Nilsson, Christian Nielsen, Dorte K Holm, et al. (+10)
5 [GO] 2023―Apr―07 Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines Amnuay Kleebayoon, Viroj Wiwanitkit
6 [GO] 2023―Mar―08 Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study Araceli Alonso-Canovas, Monica M Kurtis, Victor Gomez-Mayordomo, Daniel Macías-García, Álvaro Gutiérrez Viedma, Elisabet Mondragón Rezola, et al. (+5)
7 [GO] 2023―Jan―03 Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology Keigo Kihara, Makoto Kinoshita, Tomoyuki Sugimoto, Shuhei Okazaki, Hisashi Murata, Shohei Beppu, et al. (+5)
8 [GO] 2022―Dec―23 SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis Zoé L E van Kempen, Eileen W Stalman, Maurice Steenhuis, Laura Y L Kummer, Koos P J van Dam, Maarten F Wilbrink, et al. (+7)
9 [GO] 2022―Dec―17 10 What can we learn from the nervous sequelae of past pandemics? Mark Honigsbaum
10 [GO] 2022―Dec―15 Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies Alessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, et al. (+18)
11 [GO] 2022―Sep―22 Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations Domenico Plantone, Sara Locci, Laura Bergantini, Carlo Manco, Rosa Cortese, Martina Meocci, et al. (+4)
12 [GO] 2022―Aug―25 Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19) Alexandra Kachaner, Cédric Lemogne, Julie Dave, Brigitte Ranque, Thomas de Broucker, Elodie Meppiel
13 [GO] 2022―Aug―12 Epilepsy mortality in Wales during COVID-19 Helen Daniels, Arron S Lacey, David Mikadze, Ashley Akbari, Beata Fonferko-Shadrach, Joe Jolling-Hurst, et al. (+4)
14 [GO] 2022―Aug―12 200 Covid-19 and acute ischaemic strokes in CADASIL: a systematic review of the literature Yassine Noui, Owain Williams, Nathan Chan, Julie Chandra, Laszlo Sztriha
15 [GO] 2022―Aug―12 203 A case of post COVID-19 endotheliitis Timothy Prossor, Gerolemos Christofi
16 [GO] 2022―Aug―12 110 Outcome and mortality of hospital admission with COVID-19 for individuals with parkinsonian syndromes Lexy Sorrell, Angela King, Jemma Inches, Jane Rideout, Robert Sneyd, Christopher Kobylecki, et al. (+4)
17 [GO] 2022―Aug―12 016 The evolution of neurological admissions preceding and during the Covid-19 pandemic Prisca Singh, Ghaniah Hassan-Smith
18 [GO] 2022―Aug―12 027 Patient reported experience of acute neurology telephone clinics during COVID-19 pandemic Kit Wu, Anna Alexandratou, Rahma Beyrouti, Pubudu Amarasena, Rachel King, Rob Weeks
19 [GO] 2022―Aug―12 127 Effect of reduced blood monitoring frequency in patients on dimethyl fumarate during the COVID-19 pandemic David Vaughan, Obioma Orazulume, Magnus Fugger, Wallace Brownlee
20 [GO] 2022―Aug―12 012 Neurological signs in a general neurology face to face clinic during the Covid-19 pandemic Udo Wieshmann
21 [GO] 2022―Aug―12 048 Impact of the COVID-19 pandemic on Creutzfeldt-Jakob disease surveillance and patient care in the UK Neil Watson, Jack Kirby, Hatice Kurudzhu, Margaret Leitch, Janet MacKenzie, Blaire Smith-Bathgate, et al. (+4)
22 [GO] 2022―Aug―12 030 Post COVID-19 syndrome dysautonomia: a tertiary referral centre experience Sean Apap Mangion, Grace Oommen, Ekawat VIchayanrat, Melissa Heightman, Toby Hillman, Robert Bell, et al. (+4)
23 [GO] 2022―Aug―12 COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database Ryan YS Keh, Sophie Scanlon, Katherine Donegan, Sally Cavanagh, Mark Foster, David Skelland, et al. (+4)
24 [GO] 2022―Aug―12 Effectiveness of COVID-19 vaccines in multiple sclerosis patients receiving disease-modifying therapies in England Afagh Garjani, Sameer Patel, Graham R Law, Dhiren Bharkhada, Waqar Rashid, Alasdair Coles, Nikos Evangelou
25 [GO] 2022―Aug―12 Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort Alexander Grundmann, Marc Hardwick, Chieh-Hsi Wu, Malcolm Semple, Dankmar Böhning, Sarah Pett, et al. (+3)
26 [GO] 2022―Aug―12 Acute inflammatory CNS diseases following vaccination against SARS-CoV-2 Anna Francis, Valentina Camera, Kariem Elhadd, Matthew Craner, Katherine Attfield, Astrid Iversen, et al. (+3)
27 [GO] 2022―Aug―12 126 The provision of anti-CD20 therapy in inflammatory demyelinating disorders of the CNS during SARS-CoV-2 Imogen Smedley, Jonathan O’Riordan
28 [GO] 2022―Aug―12 003 A case of SARS-CoV-2 Omicron variant associated acute encephalomyelitis Michelle Dsouza, Nicole Lichtblau, Sarah Siddiqui, Sreedharan Harikrishnan, Nidal Abukhayzaran, Samuel Moses, Kristina Lauckaite
29 [GO] 2022―Aug―12 118 Acute disseminated encephalomyelitis associated with SARS-CoV-2 vaccine in multiple sclerosis: a case report Matthew Evans, Georgina Hanbury, Emma Lim, Luke Dixon, Victoria Singh-Curry, Richard Nicholas
30 [GO] 2022―Aug―12 021 Experience from a SARS-CoV2 neurology clinic at the national hospital of neurology and neurosurgery Simeona Jacinto, Alex Berry, Viva Levee, Melissa Heightman, Toby Hillman, Valeria Iodice, et al. (+4)
31 [GO] 2022―Aug―12 023 Impact of pandemic on neurologists and neurology practice Christopher Kipps, Catherine Mummery
32 [GO] 2022―Aug―11 Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study Matthieu Gasnier, Walid Choucha, Francois Radiguer, Theo Faulet, Kenneth Chappell, Aurore Bougarel, et al. (+18)
33 [GO] 2022―Jul―28 Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
34 [GO] 2022―Jul―14 SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod Lil Meyer-Arndt, Julian Braun, Florent Fauchere, Kanika Vanshylla, Lucie Loyal, Larissa Henze, et al. (+19)
35 [GO] 2022―Jun―14 Parsonage-Turner syndrome following COVID-19 vaccination Young Gi Min, Jee-Eun Kim, Ji Young Hwang, Je-Young Shin, Jung-Joon Sung, Yoon-Ho Hong
36 [GO] 2022―Jun―10 Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, et al. (+3)
37 [GO] 2022―May―27 041 Posterior reversible encephalopathy syndrome (PRES) in mild and severe COVID-19 Philip Hayton, Hisham Hamdalla
38 [GO] 2022―May―27 COVID-19 and multiple sclerosis: An updated report of the community-based longitudinal UK MS Register study Afagh Garjani, Rodden M Middleton, Graham R Law, Katherine Tuite-Dalton, Rachael Hunter, Roshan das Nair, et al. (+2)
39 [GO] 2022―May―27 074 COVID-19 as a cause of coma in adult onset vanishing white matter disease Sara Leddy, Steven Barden, Nicholas Skipper, Romi Saha
40 [GO] 2022―May―27 096 COVID-19 in MS: clinically reported outcomes from the UK MS register Rod Middleton, Elaine Craig, William Rodgers, Katie Tuite-Dalton, Afagh Garjani, Nikos Evangelou, et al. (+3)
41 [GO] 2022―May―27 126 A case report of the emergence of neurosarcoidosis after COVID-19 infection Rebecca Robinson, Adam Nelson, Stella Hughes, Michael Kinney
42 [GO] 2022―May―27 008 Association of COVID-19 infections with new-onset and breakthrough epileptic seizures Hardik Bhaskar, Neeraj Singh
43 [GO] 2022―May―27 067 Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension Mark Thaller, George Tsermoulas, Rosa Sun, Susan Mollan, Alexandra Sinclair
44 [GO] 2022―May―27 102 Translating logistical challenges into service improvement: MS infusional services during the covid-19 pandemic Stephen Ramsay, Fiona Magill, Glenn Cartmill, Grainne Goldsmith, Jon McKee, Fiona Kennedy, et al. (+3)
45 [GO] 2022―May―27 097 Disability and quality of life changes in people with MS (pwMS) throughout the COVID-19 pandemic William Rodgers, Rod Middleton, James Witts, Brooke Lumicisi, Richard Nicholas
46 [GO] 2022―May―27 032 Improving access to inpatient ambulatory cardiac monitoring for acute stroke patients during the Covid-19 pandemic Harriet Jeffery, Elena Rivero Sanz, David Turner
47 [GO] 2022―May―27 083 The impact of the Covid-19 pandemic on neurology outpatients services at Watford General Hospital Mayu Teranaka, Harry Mitchell, Krista Farrell
48 [GO] 2022―May―27 079 The impact of the COVID-19 pandemic on the mental health of MND patients Abigail Gilchrist, Amina Chaouch, John Ealing, Hisham Hamdalla, Sharon Coen
49 [GO] 2022―May―27 081 Comparison of 100 remotely assessed neurology outpatients during the COVID-19 pandemic with a 2019 cohort James Pigott, Jacob McCammon, Arani Nitkunan
50 [GO] 2022―May―27 082 Experiences of remote consulting for neurologists and patients during the COVID-19 pandemic: a national survey Maria Stavrou, Lioutas Eva, Lioutas Joanna, Richard Davenport
51 [GO] 2022―May―27 089 COVID-19 vaccinations in multiple sclerosis: UK MS register participant survey Yun Huang, Aravindhan Baheerathan, Rodden Middleton, William Rodgers, Katherine Tuite Dalton, Richard Nicholas
52 [GO] 2022―May―27 039 Cerebral venous sinus thrombosis and COVID-19: causation or coincidence? James Crawford, Hannah Taylor, Hajira Iftikhar, David McKee, Amina Chaouch
53 [GO] 2022―May―27 Neurologic and radiographic findings associated with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) Omar Abdel-Mannan, Justin Penner, Jane Hassell, Ulrike Loebel, Sue Maillard, Mae Johnson, et al. (+4)
54 [GO] 2022―May―27 103 Virtual multiple sclerosis (MS) clinics during a global pandemic: the patients’ perspective Stephen Ramsay, Niamh Turley, Fiona Magill, Grainne Goldsmith, Jon McKee, Fiona Kennedy, et al. (+3)
55 [GO] 2022―May―23 Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study Lucilla Vestito, Laura Mori, Carlo Trompetto, Diego Bagnasco, Rikki F Canevari, Marta Ponzano, et al. (+5)
56 [GO] 2022―Mar―10 Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study Thomas Williams, Rhea Mishra, Brina Bharkhada, Aoife Shields, Rachel Dorsey, Jeremy Chataway, Wallace J Brownlee
57 [GO] 2022―Mar―04 Consider alternative causes before allocating acute ischaemic stroke to COVID-19 Josef Finsterer
58 [GO] 2022―Feb―22 Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab Saskia Räuber, Melanie Korsen, Niklas Huntemann, Leoni Rolfes, Thomas Müntefering, Vera Dobelmann, et al. (+18)
59 [GO] 2022―Jan―25 Acute ischaemic stroke associated with SARS-CoV-2 infection in North America Adam A Dmytriw, Mahmoud Dibas, Kevin Phan, Aslan Efendizade, Ospel Johanna, Clemens Schirmer, et al. (+62)
60 [GO] 2021―Sep―29 Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination Christina Crossette-Thambiah, Charis Pericleous, Namir Asmar, Joshua Bomsztyk, Amita Ranger, Abdul Shlebak, et al. (+4)
61 [GO] 2021―Sep―28 Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app Kerstin Klaser, Ellen J Thompson, Long H Nguyen, Carole H Sudre, Michela Antonelli, Benjamin Murray, et al. (+19)
62 [GO] 2021―Aug―18 Functional disorders after COVID-19 vaccine fuel vaccination hesitancy Alfonso Fasano, Antonio Daniele
63 [GO] 2021―Aug―18 mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla, Valentina Torri Clerici, et al. (+26)
64 [GO] 2021―Aug―06 Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder Matt Butler, Arina Tamborska, Greta K Wood, Mark Ellul, Rhys H Thomas, Ian Galea, et al. (+6)
65 [GO] 2021―Aug―05 Vaccination and multiple sclerosis in the era of the COVID-19 pandemic Tobias Monschein, Hans-Peter Hartung, Tobias Zrzavy, Michael Barnett, Nina Boxberger, Thomas Berger, et al. (+4)
66 [GO] 2021―Aug―02 Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders Céline Louapre, Michella Ibrahim, Elisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, et al. (+8)
67 [GO] 2021―Jul―16 7 Covid-19 and neuropsychiatry Benedict D Michael
68 [GO] 2021―Jul―16 #3125 Novel framework for neurocognitive COVID-19 assessment Jai Mathur, Alan Carson
69 [GO] 2021―Jul―16 #3123 Assessing international alcohol and internet use patterns during COVID-19 isolation using an online survey: highlighting distinct stressors conferring risk to compulsive behaviours Samantha N Sallie, Valentin JE Ritou, Henrietta Bowden-Jones, Valerie Voon
70 [GO] 2021―Jul―14 Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine Guendalina Beatrice Bonifacio, Dharmini Patel, Sarah Cook, Elena Purcaru, Michael Couzins, Janine Domjan, et al. (+8)
71 [GO] 2021―Jun―04 Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives Jonathan P Rogers, Cameron J Watson, James Badenoch, Benjamin Cross, Matthew Butler, Jia Song, et al. (+24)
72 [GO] 2021―May―26 Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself Hugh S Markus
73 [GO] 2021―May―26 Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia Talal Al-Mayhani, Sadia Saber, Matthew J Stubbs, Nicholas A Losseff, Richard J Perry, Robert J Simister, et al. (+4)
74 [GO] 2021―Apr―27 Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong Florence Sin Ying Fan, Terry C F Yip, Brian Yiu, Bonnie Lam, Lisa Au, Alexander Yuk-lun Lau, et al. (+7)
75 [GO] 2021―Apr―21 Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study Georgios Tsivgoulis, Paraskevi C. Fragkou, Emmanouil Karofylakis, Maria Paneta, Konstantinos Papathanasiou, Lina Palaiodimou, et al. (+5)
76 [GO] 2021―Mar―12 Correction: Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America
77 [GO] 2020―Dec―24 Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension Mark Thaller, Georgios Tsermoulas, Rosa Sun, Susan P Mollan, Alexandra J Sinclair
78 [GO] 2020―Nov―20 Pattern of cognitive deficits in severe COVID-19 Valérie Beaud, Sonia Crottaz-Herbette, Vincent Dunet, Julien Vaucher, Raphaël Bernard-Valnet, Renaud Du Pasquier, et al. (+2)
79 [GO] 2020―Nov―06 Epileptiform activity and seizures in patients with COVID-19 Fabiane Santos de Lima, Naoum Issa, Kaitlin Seibert, Jared Davis, Richard Wlodarski, Sara Klein, et al. (+5)
80 [GO] 2020―Nov―06 Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study Richard J Perry, Craig J Smith, Christine Roffe, Robert J Simister, Saravanan Narayanamoorthi, Richard Marigold, et al. (+14)
81 [GO] 2020―Nov―06 Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions Massimiliano Filosto, Stefano Cotti Piccinelli, Stefano Gazzina, Camillo Foresti, Barbara Frigeni, Maria Cristina Servalli, et al. (+39)
82 [GO] 2020―Oct―29 Ischaemic strokes associated with COVID-19: is there a specific pattern? Edouard Januel, Laure Bottin, Marion Yger, Anne Leger, Sophie Crozier, Flore Baronnet, et al. (+10)
83 [GO] 2020―Oct―28 Intravenous thrombolysis for acute ischaemic stroke during COVID-19 pandemic in Wuhan, China: a multicentre, retrospective cohort study Yifan Zhou, Candong Hong, Jiang Chang, Yuanpeng Xia, Huijuan Jin, Yanan Li, et al. (+9)
84 [GO] 2020―Oct―14 COVID-19 impact on consecutive neurological patients admitted to the emergency department Andrea Pilotto, Alberto Benussi, Ilenia Libri, Stefano Masciocchi, Loris Poli, Enrico Premi, et al. (+39)
85 [GO] 2020―Sep―18 Increased ethnicity and socioeconomic data collection required in stroke associated with COVID-19 Danish Hafeez, Jia Song, Cameron Watson, Alasdair Rooney, Timothy R Nicholson
86 [GO] 2020―Aug―28 Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection Carlo Civardi, Alessandra Collini, Dinha Joan Geda, Claudio Geda
87 [GO] 2020―Aug―27 Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology Luke Dixon, Charles Coughlan, Kushan Karunaratne, Nikolaos Gorgoraptis, James Varley, James Husselbee, et al. (+8)
88 [GO] 2020―Aug―27 Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register Nikos Evangelou, Afagh Garjani, Roshan dasNair, Rachael Hunter, Katherine A Tuite-Dalton, Elaine M Craig, et al. (+13)
89 [GO] 2020―Aug―27 High mortality rate in COVID-19-associated stroke, analysis of risk factors Leonardo Renieri
90 [GO] 2020―Aug―27 Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic Antonino Uncini, Jean-Michel Vallat, Bart C Jacobs
91 [GO] 2020―Aug―14 Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America Adam A Dmytriw, Kevin Phan, Clemens Schirmer, Fabio Settecase, Manraj K S Heran, Aslan Efendizade, et al. (+14)
92 [GO] 2020―Jul―30 Guillain-Barré syndrome in times of pandemics Sonja E Leonhard, David R Cornblath, Hubert P Endtz, James J Sejvar, Bart C Jacobs
93 [GO] 2020―Jul―27 Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection Abdenour Djellaoui, Lilia Seddik, Laurent Cleret De Langavant, Samuel Cattan, Anne Catherine Bachoud-Lévi, Hassan Hosseini
94 [GO] 2020―Jul―20 Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke Fadi Al Saiegh, Ritam Ghosh, Adam Leibold, Michael B Avery, Richard F Schmidt, Thana Theofanis, et al. (+9)
95 [GO] 2020―Jul―20 Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study Guo Li, Jinfeng Miao, Hui Wang, Shabei Xu, Wenzhe Sun, Yebin Fan, et al. (+4)
96 [GO] 2020―Jul―13 A case of limbic encephalitis associated with asymptomatic COVID-19 infection Laura Zambreanu, Sophie Lightbody, Mohit Bhandari, Chandrashekar Hoskote, Hala Kandil, Catherine F Houlihan, Michael P Lunn
97 [GO] 2020―Jul―10 COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network Louis Delamarre, Cédric Gollion, Gaspard Grouteau, David Rousset, Guillaume Jimena, Jérôme Roustan, et al. (+13)
98 [GO] 2020―Jul―10 Management of patients with generalised myasthenia gravis and COVID-19: four case reports Annemarie Hübers, Agustina M Lascano, Patrice H Lalive
99 [GO] 2020―Jul―07 Postinfectious brainstem encephalitis associated with SARS-CoV-2 Anthony Khoo, Benjamin McLoughlin, Sanjay Cheema, Rimona S Weil, Christian Lambert, Hadi Manji, et al. (+2)
100 [GO] 2020―Jun―23 Nervous system: subclinical target of SARS-CoV-2 infection Sara Mariotto, Alessia Savoldi, Katia Donadello, Serena Zanzoni, Silvia Bozzetti, Sara Carta, et al. (+15)
101 [GO] 2020―Jun―05 Defining causality in COVID-19 and neurological disorders Mark Ellul, Aravinthan Varatharaj, Timothy R Nicholson, Thomas Arthur Pollak, Naomi Thomas, Ava Easton, et al. (+10)
102 [GO] 2020―Apr―30 Characteristics of ischaemic stroke associated with COVID-19 Rahma Beyrouti, Matthew E Adams, Laura Benjamin, Hannah Cohen, Simon F Farmer, Yee Yen Goh, et al. (+9)
103 [GO] 2020―Apr―20 Neurology in the time of covid-19 Hadi Manji, Aisling S Carr, Wallace J Brownlee, Michael P Lunn
104 [GO] 2020―Apr―20 Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 Kaiming Liu, Mengxiong Pan, Zheman Xiao, Xiaopei Xu

104 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec